Immutep Announces KOL Event Focused on Eftilagimod Alpha in Non-Small Cell Lung Cancer and Head & Neck Squamous Cell Carcinoma May 2, 2023 08:00AM
Immutep to Participate in Two Upcoming Investor Conferences Sep 26, 2022 08:00AM
Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference Sep 26, 2018 08:00AM